Correction to: Nature Communications https://doi.org/10.1038/s41467-020-15562-9, published online 27 March 2020.
The original version of the Supplementary Information associated with this Article contained inadvertent errors in Supplementary Fig. 2, in which the image showing results for experiments with TMPRSS4 and SARS-CoV S was duplicated for experiments with TMPRSS4 and SARS-CoV-2 S and the image showing results for experiments with TMPRSS11A and SARS-CoV S was duplicated for experiments with TMPRSS11A and SARS-CoV-2 S. The HTML has been updated to include a corrected version of the Supplementary Information.
Author information
Authors and Affiliations
Corresponding authors
Supplementary information
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Ou, X., Liu, Y., Lei, X. et al. Author Correction: Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun 12, 2144 (2021). https://doi.org/10.1038/s41467-021-22614-1
Published:
DOI: https://doi.org/10.1038/s41467-021-22614-1
This article is cited by
-
The SARS-CoV-2 nucleocapsid protein: its role in the viral life cycle, structure and functions, and use as a potential target in the development of vaccines and diagnostics
Virology Journal (2023)
-
A multi-population-based genomic analysis uncovers unique haplotype variants and crucial mutant genes in SARS-CoV-2
Journal of Genetic Engineering and Biotechnology (2022)
-
Immunomolecular assay based on selective virion capture by spike antibody and viral nucleic acid amplification for detecting intact SARS-CoV-2 particles
Journal of Nanobiotechnology (2022)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
